Skip to main content
. 2021 Feb 5;13(2):120. doi: 10.3390/toxins13020120

Table 7.

Studies on the use of BoNT-A in notalgia paresthetica.

First Author [Ref.], year Type of Study n BoNT-A Doses Retreatment Follow-Up Results
Maari [126], 2014 RCT vs. placebo double-blind 20 max 200 U No 12 weeks, then placebo arm shifted to BoNT-A; total 24 weeks No significant difference for pruritus (VAS) and hyperpigmentation
Pèrez-Pèrez [57], 2014 Retrospective, case series 5 48–56 U No 18 months 2 worsening pruritus, little improvement in other 3 but for only 1 month
Wallengren [125], 2010 Prospective 6 18–100 U No 18 months 5/6 patients a mean reduction of VAS by 28% at week 6; at 18 months 1 patient had a VAS of 45%, another one was still free from itch
Weinfeld [124], 2007 Case report 2 16–24 U Yes, 18 months later with 48 U (only 1 patient) 18 months Improvement (patient self-assessment)